1. ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series. (27th April 2022) Authors: Ambrosini, Margherita; Del Re, Marzia; Manca, Paolo; Hendifar, Andrew; Drilon, Alexander; Harada, Guilherme; Ree, Anne Hansen; Klempner, Samuel; Mælandsmo, Gunhild Mari; Flatmark, Kjersti; Russnes, Hege G.; Cleary, James M.; Singh, Harshabad; Sottotetti, Elisa; Martinetti, Antonia; Randon, Giovan... Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Issue 1 (12th July 2021) Authors: Rye, Inga Hansine; Huse, Kanutte; Josefsson, Sarah E.; Kildal, Wanja; Danielsen, Håvard E.; Schlichting, Ellen; Garred, Øystein; Riis, Margit L.; OSBREAC, ; Lingjærde, Ole Christian; Myklebust, June H.; Russnes, Hege G. Journal: Molecular oncology Issue: Volume 16:Issue 1(2022) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical trials in the era of precision cancer medicine – for the few or for the many?. (2nd July 2020) Authors: Russnes, Hege G. Journal: Acta oncologica Issue: Volume 59:Number 7(2020) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study. (3rd August 2022) Authors: Ree, Anne Hansen; Mælandsmo, Gunhild M.; Flatmark, Kjersti; Russnes, Hege G.; Gómez Castañeda, Mónica; Aas, Eline Journal: Acta oncologica Issue: Volume 61:Number 8(2022) Page Start: 955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models. (November 2022) Authors: Flobak, Åsmund; Skånland, Sigrid S.; Hovig, Eivind; Taskén, Kjetil; Russnes, Hege G. Journal: Trends in pharmacological sciences Issue: Volume 43:Number 11(2022) Page Start: 973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glycan‐related gene expression signatures in breast cancer subtypes; relation to survival. Issue 4 (14th January 2015) Authors: Potapenko, Ivan O.; Lüders, Torben; Russnes, Hege G.; Helland, Åslaug; Sørlie, Therese; Kristensen, Vessela N.; Nord, Silje; Lingjærde, Ole C.; Børresen-Dale, Anne-Lise; Haakensen, Vilde D. Journal: Molecular oncology Issue: Volume 9:Issue 4(2015:Apr.) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors. Issue 11 (21st September 2018) Authors: Rye, Inga H.; Trinh, Anne; Sætersdal, Anna B.; Nebdal, Daniel; Lingjærde, Ole Christian; Almendro, Vanessa; Polyak, Kornelia; Børresen‐Dale, Anne‐Lise; Helland, Åslaug; Markowetz, Florian; Russnes, Hege G. Journal: Molecular oncology Issue: Volume 12:Issue 11(2018) Page Start: 1838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ipilimumab in a real‐world population: A prospective Phase IV trial with long‐term follow‐up. Issue 1 (9th September 2021) Authors: Aamdal, Elin; Jacobsen, Kari D.; Straume, Oddbjørn; Kersten, Christian; Herlofsen, Oluf; Karlsen, Jarle; Hussain, Israr; Amundsen, Anita; Dalhaug, Astrid; Nyakas, Marta; Schuster, Cornelia; Hagene, Kirsten T.; Holmsen, Kjersti; Russnes, Hege G.; Skovlund, Eva; Kaasa, Stein; Aamdal, Steinar; Kyte,... Journal: International journal of cancer Issue: Volume 150:Issue 1(2022) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer – the MetAction study. (2nd July 2020) Authors: Ree, Anne Hansen; Nygaard, Vigdis; Boye, Kjetil; Heinrich, Daniel; Dueland, Svein; Bergheim, Inger Riise; Johansen, Christin; Beiske, Klaus; Negård, Anne; Lund-Iversen, Marius; Nygaard, Vegard; Hovig, Eivind; Nakken, Sigve; Nasser, Salah; Julsrud, Lars; Reisse, Claudius H.; Ruud, Espen A.; Kriste... Journal: Acta oncologica Issue: Volume 59:Number 7(2020) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors. Issue 4 (26th December 2014) Authors: Rye, Inga H.; Lundin, Pär; Månér, Susanne; Fjelldal, Renathe; Naume, Bjørn; Wigler, Michael; Hicks, James; Børresen‐Dale, Anne‐Lise; Zetterberg, Anders; Russnes, Hege G. Journal: Genes, chromosomes & cancer Issue: Volume 54:Issue 4(2015:Apr.) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗